Filing Details
- Accession Number:
- 0001401708-20-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-02 16:05:53
- Reporting Period:
- 2020-02-27
- Accepted Time:
- 2020-03-02 16:05:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1401708 | Nanostring Technologies Inc | NSTG | Biological Products, (No Disgnostic Substances) (2836) | 200094687 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1592508 | W. David Ghesquiere | 530 Fairview Avenue N Seattle WA 98109 | Svp, Corporate & Business Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-27 | 22,000 | $12.50 | 76,169 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-27 | 22,000 | $35.09 | 54,169 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2020-02-27 | 22,000 | $12.50 | 22,000 | $12.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
51,421 | 2023-12-04 | No | 4 | M | Direct |
Footnotes
- The sales reported by Mr. Ghesquiere were effected pursuant to a Rule 10b5-1 trading plan adopted on June 13, 2019.
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- 25% of the shares subject to the Option vest on the one year anniversary of December 5, 2013 (the "Vesting Commencement Date"), and thereafter 1/48th of the shares subject to the Option shall vest each monthly anniversary of the Vesting Commencement Date.